‘Next Generation Flow Diverter for the Treatment of Intracranial Aneurysms Delivering Improved Patient Outcomes and Healthcare Cost Savings — OXIFLOW’ This project […]
The Birth of Oxford Endovascular – Interview with Beth Suzanne.
Oxford Endovascular kick starts its next fund raise following strong pre-clinical results
Oxford Endovascular in GLP phase with its brain aneurysm treatment device Oxford Endovascular Limited CEO Mike Karim spoke with Proactive Investors at […]
Oxford Endovascular, a spin-out from Oxford University, has used ‘origami engineering for the brain’ to develop a unique, patented, next-generation flow-diverter (OxiFlow) […]
On Monday, November 12th at 1600, Oxford Endovascular appeared live on ‘The Series A Hour with Match Capital’. This second series of […]
The company successfully raises £2.5M to continue its development work and progression through its animal studies over 2018/2019 in advance of making […]
EIT Health Spain has announced the winning start-ups who will compete in the medical technology category in the European Health Catapult Contest. […]
Abingdon, UK, 6 October 2017: – OBN (UK) Ltd, the membership organisation that supports the life sciences industry, are delighted to announce the […]
OBN, the membership organisation that supports innovative life sciences companies, today announces that Mike Karim, CEO of Oxford Endovascular is the winner of […]
